A Study to Evaluate Preventive Treatments for Talquetamab-related Oral Toxicity
Status:
RECRUITING
Trial end date:
2027-10-18
Target enrollment:
Participant gender:
Summary
The purpose of this study is to identify preventive treatments that can minimize the occurrence, severity, and duration of talquetamab-related taste changes (dysgeusia), during the prophylaxis (preventive) treatment phase, and to better characterize the signs or symptoms of talquetamab-related taste changes.